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http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose: Epigenetic alterations such as DNA methylation and histone acetylation
are described as changes in the pattern of gene expression not involving the DNA sequence.
Lipopolysaccharide (LPS) derived from Porphyromonas gingivalis has been shown to inhibit
osteoblastic cell differentiation. We examined whether DNA hypermethylation was involved
in the inhibitory effect of LPS on osteoblastic differentiation of fibroblasts derived from human
periodontal ligament (HPDL).
Methods: TheHPDL cellswere incubatedwith LPS derived from P. gingivalis at a concentration of
10 mg/ml for 24 h. The cells were treated with DNA methyltransferase inhibitor 5-Aza-2’-deoxy-
cytidine (5Aza). Untreated cells were used as a control. Cell viability was determined using cell
proliferation reagent. DNA methyltransferase (DNMT1) and runt-related transcription factor 2
(RUNX2) mRNAs were evaluated by quantitative polymerase chain reaction (RT-PCR). Analysis
of RUNX2 DNA methylation was performed using quantitative methylation-specific PCR.Oral Microbiology, School of Dentistry, Health Sciences University of Hokkaido, 1757 Kanazawa,
Japan.
yo-u.ac.jp (F. Nakazawa).
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LPS induce DNA hypermethylation of RUNX2 177Results: The expression level of RUNX2 was significantly lower in the cells stimulated with LPS
than the controls. The presence of 5Aza increased the expression of RUNX2 in cells stimulated
with LPS. The expression levels of DNMT1mRNA in the cells stimulatedwith LPSwere significantly
higher than in the control. The presence of 5Aza completely abolished the upregulated expres-
sion of DNMT1 in cells stimulated with LPS. The methylation of DNA at 0.1 kb and 1.9 kb in the
cells stimulated with LPS was significantly higher than the control.
Conclusion: The results indicate that DNA hypermethylation may be involved in the inhibitory
effect of LPS on osteoblastic differentiation in HPDL.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Epigenetics is described as changes in the pattern of gene
expression not involving the DNA sequence. Epigenetic
events act through chemical modification of DNA and by
selectively activating or inactivating genes to determine
their expression during development.1 DNA methylation
and histone deacetylation are two major mechanisms of
epigenetic alteration in human cells. DNA methylation is
characterized by the addition of a methyl group to cyto-
sines within CpG regions. Histone deacetylation is a mech-
anism that involves the removal of the acetyl group leading
to alteration of the charge and packing of DNA around
histones.2 These epigenetic modifications are often
observed in malignant and premalignant lesions.3 It has
recently been shown that epigenetic modifications may
cause other common diseases such as diabetes, metabolic
diseases, allergies, autoimmune diseases, and neurode-
generative diseases.4 Epigenetic alterations have also
recently been implicated in periodontal disease.5 The
expression profiles of several cytokines may be epigeneti-
cally modified.6 Preliminary data suggest that expression of
periodontal disease-related cytokines such as IL-6 may be
altered by an epigenetic modification.7 Methylation of the
collagen-a1 gene has been observed in the periodontal
ligament during the aging process.8 Some local risk factors
for periodontal disease such as tobacco smoke, alcohol and
infectious agents can cause epigenetic modification.9,10
Epigenetic modification can be caused by certain types
of bacteria and lipopolysaccharide (LPS).11 For example,
oral pathogens including Porphyromonas gingivalis and
Fusobacterium nucleatum were recently shown to cause
epigenetic modifications.12 Epigenetic modifications such
as DNA hypermethylation often induce downregulation of
transcriptional levels.13 LPS derived from P gingivalis has
been demonstrated to inhibit osteoblastic differentiation of
osteoprogenitor cells derived from fatal rat calvaria.14
Runt-related transcription factor 2 (RUNX2) is a key tran-
scription factor associated with osteoblast differentiation,
and the inhibition of osteoblastic cell differentiation is
accompanied by downregulated expression of RUNX2.15 We
hypothesized that the downregulated expression of RUNX2
is involved in DNA hypermethylation. Fibroblasts derived
from periodontal tissues have the potential for osteoblastic
differentiation. We examined whether LPS derived from P
gingivalis caused downregulated expression of RUNX2 in
fibroblasts derived from periodontal ligaments, andwhether DNA hypermethylation is involved in the down-
regulated expression.
Methods
Cell culture
Human periodontal ligament (HPDL) cells from normal
human periodontal ligament tissue were purchased from
Lonza Walkersville (Basel, Switzerland) and cultured in
Dulbecco’s modified Eagle’s medium (Sigma-Aldrich, St.
Louis, MO, USA) containing 10% fetal bovine serum (Gibco,
Invitrogen Corporation, Carlsbad, CA, USA), 100 U/ml
penicillin and 100 mg/ml streptomycin (Sigma-Aldrich) at
37C in a humidified atmosphere of 95% air and 5% CO2.
HPDL cells were spread onto 60 mm tissue culture plates
at a density of 4.0105 cells/ml. After overnight incuba-
tion, the cells were cultured with P gingivalis LPS (LPS:
InvivoGen, San Diego, CA, USA) at a concentration of
10 mg/ml, or with 5-Aza-2’-deoxycytidine (5Aza: Sigma), an
inhibitor of DNA methyltransferase, at concentrations of
1mM, 10 mM, and 100 mM. Untreated cells were used as
controls.
In vitro cytotoxicity assays
Cell viability was determined using cell proliferation
reagent WST-1 (Roch Diagnostics, Mannheim, Germany).
HPDL cells were seeded in 96-well plates in Dulbecco’s
modified Eagle’s medium and cultured overnight. The cells
were treated with different concentrations of LPS or 5Aza.
After incubation for 12 and 24 h, 10 ml of WST-1 was added
to each well and cultured for 1 hour. The absorbance at
450 nm was determined using an Infinite F200 microplate
reader (Tecan, Ma¨nnedorf, Switzerland).
RNA extraction and quantitative RT-PCR
Total RNA was extracted from HPDL cells using an RNeasy
Mini Kit (Qiagen, Venlo, Netherlands), following the
manufacturer’s instructions. Total RNA was reversely tran-
scribed into cDNA using an Omniscript RT Kit (Qiagen).
Nucleotide contents were measured on a Nanodrop ND-1000
spectral photometer (Nanodrop Technologies, Wilmington,
DE, USA). The cDNA levels were measured using the ABI
7500 Real-Time PCR System (Applied Biosystems, Foster
Figure 1. Schematic diagram of the coverage of the CpG
islands and the retro-element distributions in the 5’-end
regions of RUNX2.
178 O. Uehara et al.City, CA, USA). Amplifications were obtained using on
demand TaqMan probes: DNMT1 (Hs00154749_m1), RUNX2
(Hs00231692_m1), and GAPDH (Hs99999905_m1; Applied
Biosystems). For the PCR (25 ml), 1.0 ml of cDNA was mixed
with 12.5 ml of 2TaqMan Universal PCR master mix
(Applied Biosystems) and TaqMan probes 1.25 ml. The PCR
conditions included initial incubation at 50C for 2 minutes,
denaturing at 95C for 10 minutes, and 40 cycles of dena-
turing at 95C for 15 seconds and annealing at 60C for 1
minutes. The relative expression of each mRNA was calcu-
lated as the Ct (the value obtained by subtracting the Ct
value of the GAPDH mRNA from the Ct value of the target
mRNA) using the DDCt method.16 Specifically, the amount
of target mRNA relative to GAPDH mRNA is expressed as
2(DCt). Data are expressed as the ratio of target mRNA to
GAPDH mRNA.
Analysis of DNA methylation
Genomic DNA was extracted from HPDL cells using the
DNeasy Blood & Tissue Kit (Qiagen). The DNA samples
(Control, LPS, 5Aza, LPSþ5Aza) were treated with sodium
bisulfite using the EpiTect Plus Bisulfite Kits (Qiagen). DNA
methylation of RUNX2 was analyzed using SYBR green-based
quantitative methylation-specific PCR (qMSP). Two sets of
PCR primers were designed using the Methyl Primer Express
Software version 1.0 (Applied Biosystems): one for unme-
thylated and one for methylated DNA sequences. The
methylated and unmethylated primers were designed
between the promoters and retro-elements shown in Fig. 1
and Tables 1 and 2. Some of the primers were designed as
described in a previous study.17 In the PCR (25 ml), 1.0 ml of
bisulfite-treated DNA template was mixed with 12.5 ml of
2 Power SYBR Green PCR Master Mix (Applied Biosystems)
and a pair of primers in a final concentration of 400 nM. The
PCR conditions included initial incubation at 50C for 2
minutes, denaturing at 95C for 10 minutes, and 40 cyclesTable 1 Summary of CpG sites
Gene
symbol
Gene description
and RefSeq ID
Gene
size (bp)
CpG isla
size (bp)
RUNX2 NM_004348 (P2 promoter) 128,905 2226of denaturing at 95C for 15 seconds and annealing at 58C
for 1 minute. After PCR amplification, a dissociation curve
was generated to confirm the size of the PCR product. The
percentage of RUNX2 methylation in a sample was esti-
mated using the following formula:
Methylated RUNX2 ð%ÞZM=Mþ U  100Z1=1þ U=M
100Z1=1þ 2DCt  100, where M is the copy number of
methylated RUNX2, U is the copy number of unmethylated
RUNX2, and DCt Z CtU  CtM.18
Statistical analysis
Statistical analysis was performed on a database using the
IBM SPSS Statistics for Windows (version 19; SPSS Inc, Chi-
cago, IL). Results were compared by the Mann-Whitney U
test and Kruskal-Wallis test with p < 0.05 accepted as
statistically significant.
Results
The cytotoxity of the inhibitor for DNA methylation, 5Aza,
was estimated by cell counts at 12 and 24 hours after the
5Aza was added to the cell culture systems, since 5Aza may
affect cell viability. No significant differences in the cell
numbers were observed between the controls and the 5Aza
samples up to 100 mM. No cytotoxic effect of 5Aza on the
cells was observed even in the presence of 10 mM LPS
(Fig. 2).
We examined whether LPS caused downregulation of
RUNX2 mRNA in HPDL cells. The expression levels were
evaluated by quantitative RT-PCR. The expression level of
RUNX2 was significantly lower in the cells stimulated with
LPS than the controls. The DNA methyltransferase inhibitor,
5Aza, increased the expression of RUNX2 in the cells stim-
ulated with LPS, although the increased expression level
was significantly lower than the control. No significant
difference in the expression level was observed between
the 5Aza samples and the control groups (Fig. 3). The
results suggest that DNA hypermethylation is, at least in
part, involved in the decreased expression of RUNX2 in the
cells stimulated with LPS. We examined whether LPS
induces DNA methylation by regulating DNA methyl-
transferase. The expression level of DNMT1 mRNA in the
cells stimulated with LPS was significantly higher than the
controls. The presence of 5Aza completely abolished the
upregulated expression of DNMT1 in the cells stimulated
with LPS (Fig. 4). In order to confirm the percentage of
methylation in RUNX2 DNA, quantitative RT-PCR was
carried out after bisulphate modification of RUNX2 DNA.nd CpG amplicon (bp) Amplicon
sitesUnmethylation (U) Methylation (M)
1947 1947 1.9 kb
852 852 0.7 kb
450 450 0.4 kb
þ21 þ21 þ0.1 kb
þ1573 þ1573 þ1.6 kb
Table 2 Primer sequences used in methylation
Amplicon
sites
Primer Forward Reverse Amplicon
Size (bp)
References
1.9 kb U GGATTTTTTGGTTTTTGTGGGT CTCTAACTAAATCAATCATTACA 127 (17)
M GATTTTTCGGTTTTTGCGGGC CTCTAACTAAATCGATCATTACG 126
0.7 kb U GGTTTTGGAAATTGTATATGGTGT AAACAACAAATCTCAAACCTACA 96 (17)
M TTTCGGAAATTGTATACGGCGC AACAACGAATCTCGAACCTACG 93
0.4 kb U TTTCGGAAATTGTATACGGC TCGTAAACAACGAATCTCGA 113 This study
M AGGTTTTGGAAATTGTATATGGT TCATAAACAACAAATCTCAAAAC 113
þ0.1 kb U GGGTGTTAGTGTATTTAGGATGT ACACAAATCTTTACCAAAATCTT 146 This study
M CGTTAGCGTATTTAGGACGC CGCAAATCTTTACCGAAATC 146
þ1.6 kb U GTTTGAGGGTGGGTGGTAGTTGT ACTACCCCAAAAAATCTAAATCA 127 (17)
M GTTTGAGGGCGGGTGGTAGTCGC ACTACCCCGAAAAATCTAAATCG 127
LPS induce DNA hypermethylation of RUNX2 179Since two CpG islands exist at the promoter areas of þ1573
to 852 and 1947 to 3061 up to approximately 3000,
we estimated the percentage of DNA methylation of these
areas using qMSP. The methylation of DNA at 0.1 kb (40%)
and 1.9 kb (20%) in the cells stimulated with LPS was
significantly higher than the control (Fig. 5).Discussion
The present study first demonstrated that P gingivalis LPS
caused DNA hypermethylation accompanied by down-
regulated expression of RUNX2 in fibroblasts derived from
the periodontal ligament. Both LPS and lipids extract from
P gingivalis inhibited osteoblastic differentiation, and the
inhibition was probably associated with downregulated
expression of RUNX2.14,15 The mechanism of downregulated
expression of RUNX2 is, however, not clear. In the present
study, the presence of 5Aza completely abolished the
upregulated expression of DNMT1 in the cells stimulated
with LPS. The RUNX2 mRNA level did not, however, revert
to the control level in the presence of 5Aza. DNA hyper-
methylation may not be fully, but at least in part, involved
in the downregulated expression of RUNX2.Figure 2. The cytotoxic effect of 5Aza on HPDL cells. The
cytotoxity of 5Aza was estimated by cell counts at 12 and 24
hours after the 5Aza was added to the cell culture system. No
significant differences in cell numbers were observed between
the controls and the 5Aza samples up to 100 mM at 12 and 24
hours. No cytotoxic effects of 5Aza were observed on HPDL
cells, even in the presence of 10 mg/ml LPS.The LPS extracted from periodontal pathogens nega-
tively affects many kinds of cells including epithelial cells,
fibroblasts, osteoblasts, and lymphocytes in the periodontal
tissues.19 These cell responses induce the development and
progression of periodontal destruction mainly via cytokine
production.20 Although epigenetic modifications are
important factors in the regulation of cell responses, little
information is available about the involvement of epige-
netic modifications in the development and progression of
periodontal destruction.21 Our results may support the
theory that epigenetic modifications are involved in the
progression of periodontal disease.
Recent studies have speculated about the role of
epigenetics in the development and progression of peri-
odontal diseases.5 Epigenetic mechanisms have been eval-
uated in some cytokine genes related to the progression of
periodontal diseases such as IL-2, IFN-g, IL-10, IL-6, and
TNF-a.22e26 The epigenome can be modified by risk factors
for periodontal disease including environment, nutrition,
tobacco smoke and alcohol, and periodontal pathogens may
also affect placental development.26e28 P gingivalis and F
nucleatum have been shown to alter the expression of
epigenetic markers in gingival epithelial cells.12 Both P
gingivalis and F nucleatum significantly decreased expres-
sion of DNMT1, indicating that these bacteria may induceFigure 3. The expression of mRNA in HPDL cells in the
presence of LPS and/or 5Aza. The expression levels of RUNX2
were evaluated by quantitative RT-PCR. The expression of
RUNX2 was significantly lower in cells stimulated with 10 mg/ml
LPS than the control (*p < 0.05). The presence of 100 mM 5Aza
increased the expression of RUNX2 in cells stimulated with
10 mg/ml LPS.
Figure 4. The expression of DNMT1 mRNA in HPDL cells in
the presence of LPS and/or 5Aza. The expression levels of
DNMT1 were evaluated by quantitative RT-PCR. The expression
of DNMT1 mRNA in cells stimulated with 10 mg/ml LPS was
significantly higher than the control (*p < 0.05). The presence
of 100 mM 5Aza completely abolished the upregulated expres-
sion of DNMT1 in cells stimulated with 10 mg/ml LPS.
180 O. Uehara et al.hypomethylation of the genes in gingival epithelial cells. In
contrast to these findings, our results showed that LPS
extract from P gingivalis significantly increased expression
of DNMT1 and induced hypermethylation of RUNX2 in HPDL
cells. The expression profile of DNMT1 by stimulated with
P gingivalis may depend on the type of cells. The gingival
epithelial cells play an important role in protective barrier
against bacterial infection, whereas HPDL cells do not.29
These functional differences between cells may be
involved in the different expression profile of DNMT1. F
nucleatum and another oral bacteria, Campylobacter
rectus, induced hypermethylation of MALT1 and Igf2
genes.28,30 LPS extracted from Escherichia coli induced
hypermethylation of Toll-like receptor 4 genes in large
intestinal epithelial cells.31 Taken together, these findings
suggest that different bacteria and their extracts may
cause different methylation changes in genes in different
types of cells.
Some studies have shown hypomethylation of RUNX2
during osteogenic and chondrogenic differentiation.Figure 5. The percentage of DNA methylation of CpG islands
areas as measured by qMSP. The percentage of metylation in
RUNX2 was estimated by quantitative RT-PCR after bisulphate
modification of RUNX2 DNA. The methylation of DNA at 0.1 kb
and 1.9 kb in cells stimulated with 10 mg/ml LPS was signifi-
cantly higher than the control (*p < 0.05).Previous studies have found hypermethylation of RUNX2 at
868 to 509; however, hypermethylation of RUNX2 is
poorly documented so far.32 We found that the hyper-
methylation site was limited to the area near the P2
promoter, at 0.1 kb ansd 1.9 kb but not at 0.7 kb.
Further studies are needed to clarify areas of frequent
hypermethylation of the RUNX2 gene.33
In conclusion, we first demonstrated that LPS extracted
from P gingivalis induced DNA hypermethylation of RUNX2
in fibroblasts derived from periodontal ligaments. LPS
causes periodontal destruction and impedes periodontal
regeneration.34 The decreased expression of RUNX2 in HPDL
cells may directly impede periodontal regeneration. DNA
hypermethylation is chemically reversible, and may there-
fore be a therapeutic target for negatively regulating gene
expression through DNA hypermethylation. There is growing
acceptance of the concept of epigenetic therapy, and
several agents that alter methylation patterns are currently
being tested in clinical trials for cancer therapy.6,35 The
findings of this study may contribute to the development of
new therapies for periodontal disease involving epigenetic
modification. The 5Aza, an inhibitor for DNA methyl-
transferase, may be one of candidates for the epigenetic
therapy.36 Recently, microRNAs have found to regulate
DNMT-associated DNA methylation in specific genes.37 The
microRNAs may be more gene-specific epigenetic therapy.
Further investigations need to establish the therapy.
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